Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 21,300 shares, a decrease of 71.1% from the March 15th total of 73,700 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average trading volume of 117,200 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Trading of Research Solutions
Several hedge funds and other institutional investors have recently added to or reduced their stakes in RSSS. Guerra Pan Advisors LLC acquired a new position in Research Solutions during the fourth quarter worth approximately $42,000. Heron Bay Capital Management purchased a new position in shares of Research Solutions in the 4th quarter valued at $50,000. Cubist Systematic Strategies LLC purchased a new stake in Research Solutions during the 4th quarter worth $56,000. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Research Solutions in the fourth quarter worth about $62,000. Finally, Millennium Management LLC purchased a new position in Research Solutions in the 4th quarter worth approximately $65,000. Hedge funds and other institutional investors own 33.60% of the company’s stock.
Research Solutions Stock Up 9.4 %
Shares of NASDAQ RSSS traded up $0.23 during midday trading on Wednesday, hitting $2.68. The company had a trading volume of 133,205 shares, compared to its average volume of 88,959. Research Solutions has a twelve month low of $2.32 and a twelve month high of $4.24. The firm has a market capitalization of $87.49 million, a price-to-earnings ratio of -17.87, a price-to-earnings-growth ratio of 4.33 and a beta of 0.61. The business has a 50-day simple moving average of $2.94 and a two-hundred day simple moving average of $3.22.
About Research Solutions
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- Dividend Payout Ratio Calculator
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Why Are These Companies Considered Blue Chips?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.